Anido Armando
- SEC CIK
- 0001219866
No open-market purchases or sales filed in the past year.
Current role at each company
- SCYX Scynexis IncDirectoras of Jun 30, 2026
- ZYNE Zynerba Pharmaceuticals, Inc.Chairman & Chief Exec. Officeras of Oct 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Anido Armando as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZYNE Zynerba Pharmaceuticals, Inc.
Chairman & Chief Exec. Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Anido ArmandoChairman & Chief Exec. Officer | SSale | −17.8K | $1.33 | −$23.7K | −1.9%936.7K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Anido ArmandoChairman & Chief Exec. Officer | SSale | −35.5K | $0.60 | −$21.3K | −5.8%576.2K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Anido ArmandoChairman & CEO | SSale | −11.9K | $1.10 | −$13.1K | −1.9%611.7K after |